Jennifer Frost and her research team at King's College London are investigating how ancient viral DNA segments affect placenta function [1].
This research is critical because understanding the genetic drivers of placental dysfunction could lead to better prevention and treatment of pregnancy complications. By identifying how these specific DNA elements influence the organ, scientists may uncover new ways to protect maternal and fetal health.
The team is focusing on elements known as transposons [1]. These are segments of viral DNA that have integrated into the genome over evolutionary time. While many of these sequences remain dormant, the research explores how they can become active and disrupt the normal functioning of the placenta [1].
The study seeks to determine why the placenta is specifically susceptible to the influence of these transposons [1]. The researchers are analyzing the mechanisms that allow these ancient viral remnants to impact cellular behavior, a process that can manifest as clinical complications during pregnancy [1].
Based in the United Kingdom, the King's College London team is examining the intersection of epigenetics and placental health [1]. Their work aims to map the relationship between these genetic triggers and the resulting physiological changes in the placenta [1].
“Ancient viral DNA segments, known as transposons, are being studied for their impact on placenta function.”
This research represents a shift toward understanding the 'dark matter' of the genome—non-coding regions and ancient viral remnants—to explain pregnancy pathologies. If the link between transposon activity and placental failure is proven, it could shift prenatal screening from purely observational metrics to genetic and epigenetic markers.
